Aqsitania will be present at the Mobile World Congress 2023 in Barcelona, from February 27th to March 2nd, within the 4YFN start-up event hall 8.1. We present our innovation for the care management of chronic pulmonary diseases: detection, diagnosis support, tele-monitoring, patient empowerment. A new way to assess pulmonary function, simple and effective, no exertion, anyone can do it by himself : “Show me how you breath, I’ll tell how you are”. Visit us at our booth 8.1A50, French pavilion, French Tech, BusinessFrance, CCI-Aquitaine #digitalhealth #TeamNAqui
Three important results were presented by Aqsitania, in collaboration with prominent clinicians, showing the capacity of our pulmonary function assessment method for diagnosis support: “just show me how you breathe”. A unique and truly disruptive innovation that opens up a large perspective in detection, follow-up and monitoring of chronic pulmonary diseases.
« Personal respiratory profiles assessed at rest ventilometry distinguished asthmatic from COPD patients » P. Hanusse 1 , P. Laveneziana 3 , F. Beaufils 2 , J. Joie 1 , C. Straus 3 , P. O. Girodet 2 , T. Similowski 3 , P. Berger 2 ;
« Personal respiratory profiles assessed at rest ventilometry predict phenotypes of asthmatic patients » P. Hanusse 1 , F. Beaufils 2 , J. Joie 1 , P. Laveneziana 3 , C. Straus 3 , T. Similowski 3 , P. O. Girodet 2 , C. Pison 4 , P. Berger 2;
« Respiratory profiles assessed by rest ventilometry predict response to bronchodilator of COPD patients » ; P. Hanusse 1 , P. Laveneziana 3 , F. Beaufils 2 , J. Joie 1 , C. Strauss 3 , P. O. Girodet 2 , P. Berger 2 , T. Similowski 3
1 AqsitaniaSAS – Pessac (France), 2 Sorbonne University – Paris (France), 3 Bordeaux University -Pessac (France)
Aqsitania is part of the WeStart program organized by the pharmaceutical laboratory Chiesi and the technological company IBM, intended to promote and industrialize its innovation for the management of chronical respiratory diseases. We talk about it in the specialized press…
- TIC Pharma : Chiesi et IBM s’allient pour améliorer l’éducation thérapeutique et l’observance des patients
- mind Health : Chiesi démarre un programme d’accompagnement de start-up avec IBM.
See you soon!
Aqsitania presents its new technology of assessment of the respiratory function, the “Ventilometry”, a cuting-edge innovation that extracts new information from rest breathing, at the ERS congress 2019 in Madrid, the world meeting of the pneumology sector!
Come and attend the presentation on 1st October 2019 entitled “Ventilometry: a new assessment of respiratory function based on tidal breathing”, authors P. Hanusse, P. Laveneziana, C. Straus, P. O. Girodet, P. Berger, T. Similowski, taking place during the session named “Lung function and respiratory muscle testing” from 10:45 to 12:45, room RETIRO. This work is carried out in collaboration with clinicians from the University Paris-Sorbonne, APHP, Hôpital de la Pitié-Salpêtrière and the University of Bordeaux, University Hospital.
Come to try Ventilometry, a real novelty in the evaluation of respiratory function, at Paris Healthcare Week / HIT 2019 congress!
This technological breakthrough allows us to offer a soft, simple test, without danger and accessible to all, allowing to track easily the stability of one’s respiratory state.
This new way to assess the respiratory function is appropriate for anyone, whatever his/her age and health condition !
People with chronical respiratory diseases like severe asthma, COPD, etc. may have highest benefits to use our services in order to secure their health.
Ventilometry is already used by several French University Hospitals and becomes open to the public thanks to its mobile version Ventilosmart.
We shall be present at Paris Healthcare Week / HIT 2019, Paris Porte-de-Versailles, lobby 7/2, booth G61, from 21st till 23rd May 2019.
See you soon!
Extra informations and a video can be found on www.ventilometry.org
Do not hesitate to leave us your details if you are interested.
We shall contact you in due course and shall spread in no way informations you sent us.
See you soon!